Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Factors other than the glomerular filtration rate that determine the serum beta-2-microglobulin level.

Stanga Z, Nock S, Medina-Escobar P, Nydegger UE, Risch M, Risch L.

PLoS One. 2013 Aug 22;8(8):e72073. doi: 10.1371/journal.pone.0072073. eCollection 2013.

2.

Serum beta2-microglobulin concentration as a novel marker to distinguish levels of risk in acute heart failure patients.

Kawai K, Kawashima S, Miyazaki T, Tajiri E, Mori M, Kitazaki K, Shirotani T, Inatome T, Yamabe H, Hirata K, Yokoyama M.

J Cardiol. 2010 Jan;55(1):99-107. doi: 10.1016/j.jjcc.2009.10.003. Epub 2009 Nov 25.

3.

Creatinine clearance, cystatin C, beta2-microglobulin and TATI as markers of renal function in patients with proteinuria.

Tramonti G, Cipollini I, Annichiarico C, Lorusso P, Panicucci E, Mariani G, Barsotti G.

J Nephrol. 2012 Nov-Dec;25(6):976-82. doi: 10.5301/jn.5000078.

PMID:
22307441
4.

Kidney function and cardiovascular disease in the hypertensive population: the ERIC-HTA study.

Redón J, Cea-Calvo L, Lozano JV, Fernández-Pérez C, Navarro J, Bonet A, González-Esteban J; ERIC-HTA 2003 Study Investigators.

J Hypertens. 2006 Apr;24(4):663-9.

PMID:
16531794
5.

Fetal serum α-1 microglobulin for renal function assessment: comparison with β2-microglobulin and cystatin C.

Nguyen C, Dreux S, Heidet L, Czerkiewicz I, Salomon LJ, Guimiot F, Schmitz T, Tsatsaris V, Boulot P, Rousseau T, Muller F.

Prenat Diagn. 2013 Aug;33(8):775-81. doi: 10.1002/pd.4128. Epub 2013 May 14.

PMID:
23592560
6.

Change in Multiple Filtration Markers and Subsequent Risk of Cardiovascular Disease and Mortality.

Rebholz CM, Grams ME, Matsushita K, Inker LA, Foster MC, Levey AS, Selvin E, Coresh J.

Clin J Am Soc Nephrol. 2015 Jun 5;10(6):941-8. doi: 10.2215/CJN.10101014. Epub 2015 Mar 30.

7.

Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in non-diabetic patients with stage 2-4 chronic kidney disease.

Malyszko J, Bachorzewska-Gajewska H, Sitniewska E, Malyszko JS, Poniatowski B, Dobrzycki S.

Ren Fail. 2008;30(6):625-8. doi: 10.1080/08860220802134607.

PMID:
18661413
8.

Cystatin C and beta2-microglobulin: markers of glomerular filtration in critically ill children.

Herrero-Morín JD, Málaga S, Fernández N, Rey C, Diéguez MA, Solís G, Concha A, Medina A.

Crit Care. 2007;11(3):R59.

9.

Measurement of renal function in kidney donors using serum cystatin C and beta(2)-microglobulin.

John GT, Fleming JJ, Talaulikar GS, Selvakumar R, Thomas PP, Jacob CK.

Ann Clin Biochem. 2003 Nov;40(Pt 6):656-8.

PMID:
14629804
10.

Urinary excretion of β2-microglobulin as a prognostic marker in immunoglobulin A nephropathy.

Shin JR, Kim SM, Yoo JS, Park JY, Kim SK, Cho JH, Jeong KH, Lee TW, Ihm CG.

Korean J Intern Med. 2014 May;29(3):334-40. doi: 10.3904/kjim.2014.29.3.334. Epub 2014 Apr 29.

11.

Serum adiponectin and cardiovascular risk in chronic kidney disease and kidney transplantation.

Chitalia N, Raja RB, Bhandara T, Agrawal P, Kaski JC, Jha V, Banerjee D.

J Nephrol. 2010 Jan-Feb;23(1):77-84.

PMID:
20091490
12.

Renal function and low-molecular-weight proteins (cystatin C, β2-microglobulin, neutrophil gelatinase-associated lipocalin) in child and young adult cancer survivors.

Stefanowicz J, Owczuk R, Aleksandrowicz E, Owczarzak A, Kurylak A, Adamkiewicz-Drożyńska E, Balcerska A.

J Pediatr Hematol Oncol. 2012 Aug;34(6):461-6. doi: 10.1097/MPH.0b013e318257fd89.

PMID:
22735883
13.

Cystatin C is not more sensitive than creatinine for detecting early renal impairment in patients with diabetes.

Oddoze C, Morange S, Portugal H, Berland Y, Dussol B.

Am J Kidney Dis. 2001 Aug;38(2):310-6.

PMID:
11479157
14.

Serum cystatin C and beta2-microglobulin as markers of glomerular filtration rate.

Jovanović D, Krstivojević P, Obradović I, Durdević V, Dukanović L.

Ren Fail. 2003 Jan;25(1):123-33.

PMID:
12617340
15.

Serum cystatin C in the United States: the Third National Health and Nutrition Examination Survey (NHANES III).

Köttgen A, Selvin E, Stevens LA, Levey AS, Van Lente F, Coresh J.

Am J Kidney Dis. 2008 Mar;51(3):385-94. doi: 10.1053/j.ajkd.2007.11.019.

PMID:
18295054
16.

Effect of lipo-prostaglandin E1 on cystatin C, β2-microglobulin, and estimated glomerular filtration rate in patients with decompensated heart failure and renal dysfunction: a single-center, nonrandomized controlled study.

Hou ZQ, Sun ZX, Su CY, Tan H, Zhong X, Hu B, Zhou Y, Shang DY.

Heart Vessels. 2013 Sep;28(5):589-95. doi: 10.1007/s00380-012-0286-x. Epub 2012 Sep 23.

PMID:
23000961
17.

Age-related change in kidney function, its influencing factors, and association with asymptomatic carotid atherosclerosis in healthy individuals--a 5-year follow-up study.

Jiang S, Sun X, Gu H, Chen Y, Xi C, Qiao X, Chen X.

Maturitas. 2012 Nov;73(3):230-8. doi: 10.1016/j.maturitas.2012.07.014. Epub 2012 Aug 27.

PMID:
22951150
18.

Two novel equations to estimate kidney function in persons aged 70 years or older.

Schaeffner ES, Ebert N, Delanaye P, Frei U, Gaedeke J, Jakob O, Kuhlmann MK, Schuchardt M, Tölle M, Ziebig R, van der Giet M, Martus P.

Ann Intern Med. 2012 Oct 2;157(7):471-81. doi: 10.7326/0003-4819-157-7-201210020-00003.

19.

Serum levels of cystatin C in patients with malignancy.

Nakai K, Kikuchi M, Fujimoto K, Kaneko Y, Omori S, Nakai K, Suwabe A.

Clin Exp Nephrol. 2008 Apr;12(2):132-9. doi: 10.1007/s10157-008-0043-8. Epub 2008 Mar 5.

PMID:
18317874
20.

Renal function and bone mineral density in community-dwelling elderly Japanese men: the Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Study.

Fujita Y, Iki M, Tamaki J, Kouda K, Yura A, Kadowaki E, Sato Y, Moon JS, Tomioka K, Okamoto N, Kurumatani N.

Bone. 2013 Sep;56(1):61-6. doi: 10.1016/j.bone.2013.05.004. Epub 2013 May 15.

PMID:
23684959

Supplemental Content

Support Center